Showing results (381-390 of 404) with videos related to
Sort By:
Pageof 41
Blood|November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedureR Hehlmann, A Hochhaus, H J Kolb, et al.Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemiaB Löwenberg, M A Boogaerts, S M Daenen, et al.Blood|June 14, 2000
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)R E Champlin, N Schmitz, M M Horowitz, et al.Bone Marrow Transplantation|January 14, 2009
Allogeneic hematopoietic SCT for patients with autoimmune diseasesT Daikeler, T Hügle, D Farge, et al.Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.Leukemia|November 1, 1996
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remissionR P Gale, T Büchner, M J Zhang, et al.Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.Pageof 41